Vaxxa AB (NGM:VAXXA)
Sweden · Delayed Price · Currency is SEK 0.4930
-0.0050 (-1.00%)
At close: Jul 30, 2026
Vaxxa AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 12.4 | 7.59 | 10.25 | 5.5 | 2.82 | 5.16 |
Cash & Short-Term Investments | 12.4 | 7.59 | 10.25 | 5.5 | 2.82 | 5.16 |
Cash Growth | 52.37% | -25.96% | 86.33% | 95.07% | -45.35% | -1.42% |
Accounts Receivable | 1.68 | 1.63 | 5.46 | 0.54 | - | 0.64 |
Other Receivables | 0.13 | 0.11 | 0.04 | 0.25 | 0.75 | 1.23 |
Receivables | 1.82 | 1.74 | 5.5 | 0.79 | 0.75 | 1.87 |
Inventory | 0.11 | 0.13 | 0.05 | - | - | - |
Prepaid Expenses | 0.31 | 0.54 | 0.15 | 0.12 | 0.07 | 0.17 |
Other Current Assets | - | - | - | 0 | - | - |
Total Current Assets | 14.63 | 10 | 15.94 | 6.41 | 3.64 | 7.19 |
Property, Plant & Equipment | 0.18 | 0.2 | 0.06 | 0.07 | - | - |
Long-Term Investments | - | - | - | - | 14 | - |
Goodwill | 3.03 | 3.73 | 5.13 | 6.54 | - | 4.29 |
Long-Term Deferred Charges | 8.3 | 8.21 | 6.67 | 4.78 | - | - |
Other Long-Term Assets | - | - | 0.02 | - | - | - |
Total Assets | 26.13 | 22.14 | 27.82 | 17.78 | 17.64 | 11.48 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.02 | 0.16 | 0.63 | 0.23 | 0.04 | 0.3 |
Accrued Expenses | 1.8 | 1.54 | 5.71 | 4.28 | 0.47 | 0.6 |
Short-Term Debt | 0.16 | 0.32 | 0.32 | - | - | - |
Current Income Taxes Payable | - | 0.11 | 0.11 | 0.06 | 0 | - |
Current Unearned Revenue | - | - | - | 0 | - | - |
Other Current Liabilities | 10.7 | 4.87 | 0.8 | 1.78 | 3.06 | 0.77 |
Total Current Liabilities | 12.68 | 6.99 | 7.58 | 6.34 | 3.57 | 1.66 |
Long-Term Debt | 0.14 | - | - | 0.41 | - | - |
Other Long-Term Liabilities | - | 0.14 | 0.46 | 0.97 | - | - |
Total Liabilities | 12.82 | 7.13 | 8.04 | 7.72 | 3.57 | 1.66 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 5.2 | 5.2 | 4.47 | 11.51 | 9.51 | 3.13 |
Additional Paid-In Capital | - | 86.77 | 82.93 | 75.2 | 77.75 | 0.55 |
Retained Earnings | - | -85.18 | -74.29 | -76.65 | -73.19 | - |
Comprehensive Income & Other | 8.11 | 8.21 | 6.67 | - | -0 | 6.15 |
Shareholders' Equity | 13.31 | 15.01 | 19.78 | 10.06 | 14.07 | 9.82 |
Total Liabilities & Equity | 26.13 | 22.14 | 27.82 | 17.78 | 17.64 | 11.48 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.3 | 0.32 | 0.32 | 0.41 | - | - |
Net Cash (Debt) | 12.1 | 7.27 | 9.93 | 5.09 | 2.82 | 5.16 |
Net Cash Growth | 54.37% | -26.80% | 95.20% | 80.38% | -45.35% | -1.42% |
Net Cash Per Share | 0.28 | 0.17 | 0.26 | 0.20 | 1.54 | 8.23 |
Filing Date Shares Outstanding | 43.37 | 43.37 | 37.23 | 23.03 | 1.83 | 0.6 |
Total Common Shares Outstanding | 43.37 | 43.37 | 37.23 | 23.03 | 1.83 | 0.6 |
Working Capital | 1.95 | 3 | 8.36 | 0.07 | 0.07 | 5.53 |
Book Value Per Share | 0.31 | 0.35 | 0.53 | 0.44 | 7.70 | 16.33 |
Tangible Book Value | 10.28 | 11.28 | 14.65 | 3.53 | 14.07 | 5.53 |
Tangible Book Value Per Share | 0.24 | 0.26 | 0.39 | 0.15 | 7.70 | 9.20 |
Machinery | - | 0.27 | 0.11 | 0.28 | - | - |